Oral minoxidil (low-dose, for hair) — evidence review — Intervention & Protocol Data

What we know

Label-derived facts remain separate from AI-generated context.

No label facts are available for this entry yet.

No AI context is available yet.

Community-supplied references. Check the linked source before relying on a claim.

Practical details pulled from scanned or cited interventions.

**Lowering of severe, refractory blood pressure** (approved use; not a hair claim).
**Increased scalp hair density / hair count in male androgenetic alopecia (AGA).**
**Increased scalp hair density / hair count in female-pattern hair loss (FPHL).**
**Increased hair-shaft diameter / thickness in AGA / FPHL.**
**Reduced shedding** (Sinclair shedding score or similar).
**Global photographic improvement** of the vertex and frontal scalp.
**Superiority of oral over topical 5% minoxidil** for density (a common claim; tested and not supported as superiority).
**Alopecia areata** — cosmetic regrowth.
**Chronic telogen effluvium** — less shedding.
**Lichen planopilaris / other scarring alopecias** — thicker background hair (not disease modification of the scar).

Dose, timing, and brands from 1 public protocol. Private and hidden usage is excluded.

Where this intervention appears and what it tends to sit beside.